PC
HAE icon

Polar Capital’s Haemonetics HAE Stock Holding History

Polar Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$464K Hold
5,322
– – ﹤0.01% 278
2020
Q2 		$477K Buy
5,322
+365
+7% +$36.9K ﹤0.01% 254
2020
Q1 		$494K Sell
4,957
-164,475
-97% -$17.8M 0.01% 269
2019
Q4 		$19.5M Buy
+169,432
New +$20.5M 0.17% 155
2017
Q2 		– Sell
-474,024
Closed -$19.2M – 248
2017
Q1 		$19.2M Buy
474,024
+50,000
+12% +$1.95M 0.29% 116
2016
Q4 		$17M Buy
+424,024
New +$16M 0.27% 117

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital's HAE Position: Q3 2020 in Review

Polar Capital held its Haemonetics (HAE) position steady in Q3 2020 at 5,322 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Polar Capital first reported a position in HAE in Q4 2016 and has held it in 6 quarters since. The position peaked at $19.5M in Q4 2019. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • Polar Capital held 5,322 shares of Haemonetics worth $464K as of Q3 2020.
  • Polar Capital left its Haemonetics share count unchanged in Q3 2020.
  • Haemonetics made up ﹤0.01% of Polar Capital's portfolio in Q3 2020, its #278 holding.
  • Polar Capital first reported a position in Haemonetics in Q4 2016 and has held it in 6 quarters since.
  • Polar Capital's Haemonetics position peaked at $19.5M in Q4 2019.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.